The FDA is considering the approval of the Novavax COVID-19 booster after delays amid controversy over its non-mRNA design.

Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...

GEO-CM04S1 Demonstrates Durable T Cell and Antibody Responses in Healthy and Immunocompromised Populations ...

NEW YORK – In cell and gene therapies, the genetic machinery is key to producing the proteins missing or dysregulated in a disease, but whether the therapeutic cassette reaches target cells and how ...

Earnings season is now in full swing, with a number of key companies due to report in the coming week, including four of the ...

TNX-801 is a single-dose, live virus vaccine in development to protect against mpox and smallpox TNX-801 protects ...